2-135218928-A-G

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_032143.4(ZRANB3):c.2352+149T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.177 (AC=97,154) in the gnomAD database across 549,536 control chromosomes, including 15,622 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.597. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.27 ( 9188 hom., cov: 32)
Exomes 𝑓: 0.14 ( 6434 hom. )

Consequence

ZRANB3
NM_032143.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.09

Publications

4 publications found
Variant links:
Genes affected
ZRANB3 (HGNC:25249): (zinc finger RANBP2-type containing 3) Enables ATP-dependent DNA/DNA annealing activity; DNA endonuclease activity; and K63-linked polyubiquitin modification-dependent protein binding activity. Involved in DNA repair; replication fork reversal; and response to UV. Located in nuclear replication fork and nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_032143.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -12 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.5974 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_032143.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

ZRANB3 NM_032143.4
MANE Select
HGVSc / HGVSpc.2352+149T>C
Exon rankIntron 16 of 20
intron
Prot: NP_115519.2UniProt: Q5FWF4-1
ZRANB3 NM_001286568.2
HGVSc / HGVSpc.2346+149T>C
Exon rankIntron 16 of 20
intron
Prot: NP_001273497.1UniProt: Q5FWF4-3
ZRANB3 NM_001286569.1
HGVSc / HGVSpc.990+149T>C
Exon rankIntron 17 of 21
intron
Prot: NP_001273498.1UniProt: F5GYN7

Ensembl Transcripts

ZRANB3 ENST00000264159.11
TSL:1MANE Select
HGVSc / HGVSpc.2352+149T>C
Exon rankIntron 16 of 20
intron
Prot: ENSP00000264159.6UniProt: Q5FWF4-1
ZRANB3 ENST00000401392.5
TSL:1
HGVSc / HGVSpc.2346+149T>C
Exon rankIntron 16 of 20
intron
Prot: ENSP00000383979.1UniProt: Q5FWF4-3
ZRANB3 ENST00000536680.5
TSL:1
HGVSc / HGVSpc.990+149T>C
Exon rankIntron 17 of 21
intron
Prot: ENSP00000441320.2UniProt: F5GYN7

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
AF: 0.268
AC:40813
Hom:9160
AN:152060
Cov:32
GnomAD4 exome
AF: 0.142
AC:56262
Hom:6434
AN:397358
GnomAD4 genome
AF: 0.269
AC:40892
Hom:9188
AN:152178
Cov:32
TOPMed (Bravo)
AF: 0.294
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.169
AC:18496
Hom:2885
AN:109516
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.283
AC:662
Hom:121
AN:2342
ChinaMAP Phase 1
AF: 0.201
Denmark Genome
AF: 0.0767
AC:23
AN:300
GenomeAsia100K
AF: 0.313
AC:1088
AN:3478
Korea4K (4,157 Koreans)
AF: 0.205
AC:1480
AN:7232
Qatari Genome
AF: 0.239
AC:42
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.218
AC:26733
Hom:2916
AN:122800
Turkish Variome
AF: 0.248
AC:383
Hom:56
AN:1546
UK10K
AF: 0.0754
AC:570
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.208
AC:1864
Hom:184
AN:8960
Showing 15 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.0847 384545378 0.0798 633379324
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Uncertain11
BayesDel_noAF
Benign-0.89
CADD
Benign3.8
DANN
Benign0.44
GPN-Star LLR
N/A1.4
GPN-Star score
N/A-1.4
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign1.1
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.